2484SP |
Lamotrigine, Serum/Plasma |
2484U |
Lamotrigine, Urine |
2488FL |
Labetalol, Fluid |
2488SP |
Labetalol, Serum/Plasma |
2492FL |
Lead, Fluid |
2492SP |
Lead, Serum/Plasma |
2492TI |
Lead, Tissue |
2492U |
Lead, Urine |
2499U |
Laxatives Panel (Qualitative), Urine |
2501SP |
Levamisole, Serum/Plasma |
2501U |
Levamisole, Urine |
2504SP |
Levodopa, Serum/Plasma |
2505SP |
Levetiracetam, Serum/Plasma |
2511SP |
Lidocaine, Serum/Plasma |
2512FL |
Lidocaine and Metabolite (MEGX), Fluid |
2512SP |
Lidocaine and Metabolite (MEGX), Serum/Plasma |
2512TI |
Lidocaine and Metabolite (MEGX), Tissue |
2512U |
Lidocaine and Metabolite (MEGX), Urine |
2516SP |
Lindane, Serum/Plasma |
2517SP |
Levocetirizine, Serum/Plasma |
2520FL |
Lithium, Fluid |
2520SP |
Lithium, Serum/Plasma |
2520TI |
Lithium, Tissue |
2520U |
Lithium, Urine |
2525SP |
Loratadine and Metabolite, Serum/Plasma |
2525U |
Loratadine and Metabolite, Urine |
2527FL |
Lacosamide, Fluid |
2527SP |
Lacosamide, Serum/Plasma |
2527U |
Lacosamide, Urine |
2531SP |
Leflunomide as Metabolite (Therapeutic Drug Monitoring), Serum/Plasma |
2532SP |
Leflunomide as Metabolite (Pre-Pregnancy Monitoring), Serum/Plasma |
2533SP |
Loperamide and Metabolite, Serum/Plasma |
2534SP |
Lithium Exposure, Serum/Plasma |
2534U |
Lithium Exposure , Urine |
2535FL |
Lorazepam, Fluid |
2535SP |
Lorazepam, Serum/Plasma |
2535U |
Lorazepam, Urine |
2538SP |
Loxapine, Serum/Plasma |
2538U |
Loxapine, Urine |
2540SP |
LSD Trace Analysis, Serum/Plasma |
2540U |
LSD Trace Analysis, Urine |
2541SP |
LSD Screen, Serum/Plasma |
2541U |
LSD Screen, Urine |
2543SP |
Lurasidone, Serum/Plasma |
2800SP |
Lisdexamfetamine as Metabolite, Serum/Plasma |
2800U |
Lisdexamfetamine as Metabolite, Urine |
9317SP |
Lidocaine and Metabolite (MEGX) Screen, Serum/Plasma |
9317U |
Lidocaine and Metabolite (MEGX) Screen, Urine |